Product Code: ETC7734530 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Chronic Hepatitis B (CHB) Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Chronic Hepatitis B (CHB) Market - Industry Life Cycle |
3.4 Japan Chronic Hepatitis B (CHB) Market - Porter's Five Forces |
3.5 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.7 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Chronic Hepatitis B (CHB) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about chronic hepatitis B and its management in Japan |
4.2.2 Technological advancements in hepatitis B treatment options |
4.2.3 Growth in healthcare infrastructure and facilities in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hepatitis B treatments |
4.3.2 High treatment costs associated with chronic hepatitis B medications |
4.3.3 Limited access to specialized healthcare services in certain regions of Japan |
5 Japan Chronic Hepatitis B (CHB) Market Trends |
6 Japan Chronic Hepatitis B (CHB) Market, By Types |
6.1 Japan Chronic Hepatitis B (CHB) Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.1.4 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Immune Modulators, 2021- 2031F |
6.2 Japan Chronic Hepatitis B (CHB) Market, By Gender |
6.2.1 Overview and Analysis |
6.2.2 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Male, 2021- 2031F |
6.2.3 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Female, 2021- 2031F |
6.3 Japan Chronic Hepatitis B (CHB) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Japan Chronic Hepatitis B (CHB) Market Revenues & Volume, By Online Providers, 2021- 2031F |
7 Japan Chronic Hepatitis B (CHB) Market Import-Export Trade Statistics |
7.1 Japan Chronic Hepatitis B (CHB) Market Export to Major Countries |
7.2 Japan Chronic Hepatitis B (CHB) Market Imports from Major Countries |
8 Japan Chronic Hepatitis B (CHB) Market Key Performance Indicators |
8.1 Number of patients diagnosed with chronic hepatitis B in Japan |
8.2 Adoption rate of new hepatitis B treatment options in the market |
8.3 Rate of adherence to prescribed hepatitis B treatment regimens |
8.4 Number of healthcare professionals specializing in hepatitis B management in Japan |
8.5 Investment in research and development of innovative hepatitis B therapies |
9 Japan Chronic Hepatitis B (CHB) Market - Opportunity Assessment |
9.1 Japan Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.3 Japan Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Chronic Hepatitis B (CHB) Market - Competitive Landscape |
10.1 Japan Chronic Hepatitis B (CHB) Market Revenue Share, By Companies, 2024 |
10.2 Japan Chronic Hepatitis B (CHB) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |